Zoetis Inc. (NYSE:ZTS) is one of the 11 Best Roth IRA Stocks to Invest in Now.
Zoetis Inc. (NYSE:ZTS) strengthened its financial flexibility on August 27, 2025, by securing a new five-year, $1.25 billion senior unsecured revolving credit facility. The agreement replaces a 2022 facility that would have expired in 2027. The agreement was administered by JPMorgan Chase, while Barclays, Bank of America, Citibank, and MUFG acted as syndication agents.
With this agreement, Zoetis Inc. (NYSE:ZTS) can avail itself of borrowing options tied to base or SOFR rates plus a margin linked to the company’s debt ratings. The move provides the company with liquidity to support operations and strategic initiatives, with no mandatory prepayments and flexible repayment terms.
Zoetis Inc. (NYSE:ZTS) prepares medicines, vaccines, diagnostics, and precision health solutions for livestock and companion animals globally. It is one of the Best Roth IRA Stocks.
While we acknowledge the potential of ZTS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Benefit From AI and 10 Must-Buy Canadian Stocks to Invest in.
Disclosure: None.